Document is current

Any future updates will be listed below

Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author’s reply

Crossref DOI link: https://doi.org/10.1007/s00134-022-06669-2

Published Online: 2022-03-15

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark